Glucotrack announced new findings from a recent market research study evaluating the acceptance of its new Continuous Blood Glucose Monitor, CBGM, concept among people with insulin-requiring diabetes. The poster was presented at the Association of Diabetes Care and Education Specialists) 2024 Annual Conference held Aug. 9-12, 2024, in New Orleans. Key features that garnered the most interest include the long-term sensor life, the absence of a wearable component, and the provision of real-time blood glucose readings. These top three appealing aspects were consistent across all segments of respondents.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GCTK:
- Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
- GlucoTrack Showcases Innovations at Industry Conference
- GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE
- GlucoTrack Secures $4M Funding and Expands Board Amid Reshuffle
- GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR